MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

Essa Pharma Inc

Geschlossen

1.69 2.42

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.6

Max

1.71

Schlüsselkennzahlen

By Trading Economics

Einkommen

2.2M

-6.4M

EPS

-0.14

Angestellte

35

EBITDA

-2.2M

-8.5M

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-444K

75M

Vorheriger Eröffnungskurs

-0.73

Vorheriger Schlusskurs

1.69

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Essa Pharma Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Juli 2025, 15:46 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250 Million Private Placement

9. Juli 2025, 23:44 UTC

Market Talk

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Global Equities Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 20:26 UTC

Ergebnisse

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9. Juli 2025, 19:18 UTC

Market Talk

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9. Juli 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9. Juli 2025, 18:31 UTC

Market Talk

Some Fed Officials Supported Considering July Cut -- Market Talk

9. Juli 2025, 17:07 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk -2-

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9. Juli 2025, 16:14 UTC

Akquisitionen, Fusionen, Übernahmen

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9. Juli 2025, 16:12 UTC

Market Talk

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9. Juli 2025, 16:08 UTC

Market Talk

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9. Juli 2025, 15:31 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250M Private Placement

9. Juli 2025, 15:31 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9. Juli 2025, 15:27 UTC

Market Talk

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9. Juli 2025, 14:36 UTC

Akquisitionen, Fusionen, Übernahmen

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9. Juli 2025, 14:31 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9. Juli 2025, 14:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

9. Juli 2025, 14:26 UTC

Market Talk

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Peer-Vergleich

Kursveränderung

Essa Pharma Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

1.7 / 1.72Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.